AAO 2024 Insights
Video Player is loading.
10 seconds
Playback speed
AAO 2024 Insights: Long-Term Follow-Up Study Results from the Investigational Phase I/IIa ABBV-RGX-314 Subretinal Delivery Gene Therapy Program in nAMD
By
AAO 2024 Insights
FEATURING
Philip Storey
By
AAO 2024 Insights
FEATURING
Philip Storey
Comments 0
Login to view comments.
Click here to Login
